Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05072457
Other study ID # SRF-387
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 18, 2021
Est. completion date July 2, 2022

Study information

Verified date May 2023
Source Sonova AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Speech intelligibility in noise will be evaluated in adults with moderate to moderate-severe sensorineural hearing loss using a Phonak Roger microphone and hearing aid with compatible Phonak Roger receiver. Target speech will be presented from multiple directions while competing diffuse background noise is presented simultaneously. Participants will repeat back words and percent correct is calculated.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date July 2, 2022
Est. primary completion date December 13, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Experienced hearing aid users, age 18 or older - Bilateral, symmetric moderate to moderate-severe sensorineural hearing loss - Good understanding of the English language - Health outer ear as confirmed by otoscopy - Informed consent as documented by signature Exclusion Criteria: - Contraindications to the medical device noted upon otoscopy - Known hypersensitivity or allergies to materials of the investigations device or comparator - Inability to produce reliable test results - Known psychological problems - Self reported symptoms of vertigo or dizziness

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Roger On microphone
Roger On microphone transmitter which is used with Roger receivers and Audeo P hearing aids
Roger Select microphone
Roger Select microphone transmitter which is used with Roger receivers and Audeo P hearing aids

Locations

Country Name City State
United States Hearts for Hearing Oklahoma City Oklahoma

Sponsors (2)

Lead Sponsor Collaborator
Sonova AG Hearts for Hearing

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lateralization Hearing Ability Participants indicate which direction (left, center, or right) target speech sentences are coming from while competing noise is also presented via four corner speakers. A higher number of correct responses indicates better lateralization ability. This will be done with two Roger microphone systems (Roger On and Roger Select) Day 1 of 1 day study
Primary Spatial Hearing Ability Participants repeat sentences presented from the left speaker, while ignoring overlapping competing sentences presented from the right speaker. A higher percentage of correctly repeated words indicates a better spatial hearing score. This task will be performed using two Roger microphone systems (Roger On and Roger Select) Day 1 of 1 day study
See also
  Status Clinical Trial Phase
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Completed NCT04601909 - FX-322 in Adults With Age-Related Sensorineural Hearing Loss Phase 1
Active, not recruiting NCT04479761 - Sensory Integration of Auditory and Visual Cues in Diverse Contexts N/A
Recruiting NCT05043207 - A Study Protocol for the Validation of UAud in a Clinical Setting. N/A
Recruiting NCT04066270 - Inventory of Radiological and Vestibular Function in Cochlear Implant Candidates
Recruiting NCT04070937 - Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy
Completed NCT03512951 - Subjective Evaluation of a Sound Processing Method for Hearing Aids on Auditory Distance Perception N/A
Active, not recruiting NCT05855005 - Direct-to-Consumer Hearing Aids and Listening Effort N/A
Recruiting NCT05599165 - Speech Perception in Bimodal Hearing N/A
Completed NCT05101083 - Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids N/A
Completed NCT05521308 - Investigating Hearing Aid Frequency Response Curves N/A
Recruiting NCT05776459 - Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) Phase 2
Completed NCT05086276 - FX-322 in Adults With Acquired Sensorineural Hearing Loss Phase 2
Recruiting NCT06058767 - Preschool Hearing Screening N/A
Completed NCT05180630 - Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems N/A
Completed NCT03613909 - Acceptance of the CP950 Sound Processor N/A
Active, not recruiting NCT03352154 - Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants N/A
Completed NCT04629664 - FX-322 in Adults With Severe Sensorineural Hearing Loss Phase 1
Completed NCT05052944 - Single-sided Deafness and Cochlear Implantation
Not yet recruiting NCT05582148 - Meniere Disease and Hearing Aids N/A